These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 32841543)

  • 1. Comparison between the effects of elective nodal irradiation and involved-field irradiation on long-term survival in thoracic esophageal squamous cell carcinoma patients: A prospective, multicenter, randomized, controlled study in China.
    Lyu J; Yisikandaer A; Li T; Zhang X; Wang X; Tian Z; Chen L; Lu B; Chen H; Yang J; Wang Q; Zhang J; Ma Y; Liu R; Liu R; Hage A; Lang J
    Cancer Med; 2020 Oct; 9(20):7460-7468. PubMed ID: 32841543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concurrent chemoradiotherapyof different radiation doses and different irradiation fields for locally advanced thoracic esophageal squamous cell carcinoma: A randomized, multicenter, phase III clinical trial.
    Zhang J; Li M; Zhang K; Zheng A; Li G; Huang W; Chen S; Chen X; Li X; Sheng Y; Sun X; Liu L; Liu X; Li J; Wang J; Ge H; Ye S; Pang Q; Zhang X; Dai S; Yu R; Gu W; Dai M; Siqin G; Han Y; Ge X; Yuan X; Yang Y; Zhu H; Pu J; Dong L; Sun X; Zhou J; Mao W; Gao F; Lin H; Gong H; Zhou T; Li Z; Li H; Wang Z; Li B
    Cancer Commun (Lond); 2024 Oct; 44(10):1173-1188. PubMed ID: 39161079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elective nodal irradiation or involved-field irradiation in definitive chemoradiotherapy for esophageal squamous cell cancer: a retrospective analysis in clinical N0 patients.
    Sun Y; Zhang XL; Mao QF; Liu YH; Kong L; Li MH
    Curr Oncol; 2018 Oct; 25(5):e423-e429. PubMed ID: 30464693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elective nodal irradiation versus involved-field irradiation in patients with esophageal cancer receiving neoadjuvant chemoradiotherapy: a network meta-analysis.
    Liu T; Ding S; Dang J; Wang H; Chen J; Li G
    Radiat Oncol; 2019 Oct; 14(1):176. PubMed ID: 31619265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of involved field radiotherapy and elective nodal irradiation in combination with concurrent chemotherapy for T1bN0M0 esophageal cancer.
    Nakatani Y; Kato K; Shoji H; Iwasa S; Honma Y; Takashima A; Ushijima T; Ito Y; Itami J; Boku N
    Int J Clin Oncol; 2020 Jun; 25(6):1098-1104. PubMed ID: 32189155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized study of involved-field irradiation versus elective nodal irradiation in combination with concurrent chemotherapy for inoperable stage III nonsmall cell lung cancer.
    Yuan S; Sun X; Li M; Yu J; Ren R; Yu Y; Li J; Liu X; Wang R; Li B; Kong L; Yin Y
    Am J Clin Oncol; 2007 Jun; 30(3):239-44. PubMed ID: 17551299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feasibility of Elective Nodal Irradiation (ENI) and Involved Field Irradiation (IFI) in Radiotherapy for the Elderly Patients (Aged ≥ 70 Years) with Esophageal Squamous Cell Cancer: A Retrospective Analysis from a Single Institute.
    Jing W; Zhu H; Guo H; Zhang Y; Shi F; Han A; Li M; Kong L; Yu J
    PLoS One; 2015; 10(12):e0143007. PubMed ID: 26636574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical outcomes of different irradiation ranges in definitive intensity-modulated radiotherapy for esophageal cancer].
    Zhu SC; Li QF; Zhang XY; Deng WZ; Song CY; Wang X; Yan K
    Zhonghua Zhong Liu Za Zhi; 2020 Dec; 42(12):1040-1047. PubMed ID: 33342161
    [No Abstract]   [Full Text] [Related]  

  • 9. Elective nodal irradiation versus involved-field irradiation for stage II-IV cervical esophageal squamous cell carcinoma patients undergoing definitive concurrent chemoradiotherapy: a retrospective propensity study with 8-year survival outcomes.
    Wang J; Wu Y; Zhang W; Chen Y; Liu Q; Jing S; Zhang J; Wu F; Wang J; Qiao X
    Radiat Oncol; 2023 Aug; 18(1):142. PubMed ID: 37641149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elective nodal irradiation provides a superior therapeutic modality for lymph node positivity esophageal squamous cell carcinoma patients receiving definitive radiotherapy versus involved-field irradiation.
    Li Q; Zhu S; Li S; Deng W
    Medicine (Baltimore); 2019 Jan; 98(3):e14080. PubMed ID: 30653123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involved-field irradiation or elective-nodal irradiation in neoadjuvant chemo-radiotherapy for locally-advanced esophageal cancer: comprehensive analysis for dosimetry, treatment-related complications, impact on lymphocyte, patterns of failure and survival.
    Chen X; Zhang Y; Zhou X; Wang M; Na F; Zhou L; Xu Y; Zou B; Xue J; Liu Y; Gong Y
    Front Oncol; 2023; 13():1274924. PubMed ID: 37886166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involved-Field Irradiation in Definitive Chemoradiotherapy for Locoregional Esophageal Squamous Cell Carcinoma: Results From the ESO-Shanghai 1 Trial.
    Zhu H; Rivin Del Campo E; Ye J; Simone CB; Zhu Z; Zhao W; Amini A; Zhou J; Wu C; Tang H; Fan M; Li L; Lin Q; Xia Y; Li Y; Li J; Mo M; Jia H; Lu S; Wang J; Nie Y; Chen J; Wu S; Hamaji M; Haque W; Jeong BK; Shridhar R; Zhang Z; Chen Y; Zhao K
    Int J Radiat Oncol Biol Phys; 2021 Aug; 110(5):1396-1406. PubMed ID: 33677048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative study of elective nodal irradiation and involved field irradiation in elderly patients with advanced esophageal cancer.
    Dai Y; Huang D; Zhao W; Wei J
    Front Oncol; 2023; 13():1323908. PubMed ID: 38173832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of elective nodal irradiation and involved-field irradiation in esophageal squamous cell carcinoma: a meta-analysis.
    Cheng YJ; Jing SW; Zhu LL; Wang J; Wang L; Liu Q; Yang CR; Wang Y; Cao F; Jiao WP; Wu YJ
    J Radiat Res; 2018 Sep; 59(5):604-615. PubMed ID: 30085197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant Radiotherapy of Involved Field versus Elective Lymph Node in Patients with Operable Esophageal Squamous Cell Cancer: A Single Institution Prospective Randomized Controlled Study.
    Liu R; Zhang X; Zhang Q; Luo H; Wei S; Liu T; Sun S; Liu Z; Li Z; Tian J; Wang X
    J Cancer; 2021; 12(11):3180-3189. PubMed ID: 33976727
    [No Abstract]   [Full Text] [Related]  

  • 16. Radiotherapy with S-1 for the treatment of esophageal squamous cell carcinoma 75 years or older.
    Gu D; Wang T; Guo Y; Liu Y; Fang Y; Chen W; Wang Q; Zhang R; Shi H; Wu D; Zhang Z; Zhou G; Ye J
    Radiat Oncol; 2024 Aug; 19(1):112. PubMed ID: 39210445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of failure after involved field radiotherapy for locally advanced esophageal squamous cell carcinoma.
    Li DJ; Li HW; He B; Wang GM; Cai HF; Duan SM; Liu JJ; Zhang YJ; Cui Z; Jiang H
    J BUON; 2016; 21(5):1268-1273. PubMed ID: 27837632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preliminary analysis of the benefits of different irradiation types on patients with postoperative locoregional recurrence of esophageal cell squamous carcinoma.
    Gao HM; Shen WB; Zhang XY; Xu JR; Li YM; Li SG; Zhu SC
    Ann Palliat Med; 2021 Sep; 10(9):9467-9479. PubMed ID: 34628872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Efficacy and Safety of Combined Chemoimmunotherapy With or Without Radiation Therapy for Stage IVB Esophageal Squamous Cell Carcinoma: A Multicenter Propensity Score Matching Analysis.
    Chen B; Chen W; Cheng Q; Zhang H; Wang B; Xu Y; Yang C; Cheng X; Wang R; Wang S; Cen P; Wang L; Dragomir MP; Zhu Y; Liu S; Xi M; Li Q; Chen B
    Int J Radiat Oncol Biol Phys; 2024 Nov; 120(4):1084-1095. PubMed ID: 38936631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemoradiotherapy with extended nodal irradiation and/or erlotinib in locally advanced oesophageal squamous cell cancer: long-term update of a randomised phase 3 trial.
    Xie C; Jing Z; Luo H; Jiang W; Ma L; Hu W; Zheng A; Li D; Ding L; Zhang H; Xie C; Lian X; Du D; Chen M; Bian X; Tan B; Xia B; Xie R; Liu Q; Wang L; Wu S
    Br J Cancer; 2020 Nov; 123(11):1616-1624. PubMed ID: 32958820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.